In today’s fast-paced experience economy, pharma companies can no longer rely on static displays and outdated engagement ...

Roche has announced that it will be advancing its Prothena-partnered investigational Parkinson’s disease (PD) drug ...

Novartis has shared positive results from a phase 3b study of Fabhalta (iptacopan) in a new population of patients with the ...

Last month, the ISPOR annual meeting in Montreal was brimming with opportunities to explore the latest developments and ...

Medscape Education, a global leader in healthcare education, proudly announces the official launch of its Center of ...